GBIO Stock Analysis: Buy, Sell, or Hold?
GBIO - Generation Bio Co. Common Stock
$5.34
-0.40 (-6.97%)
▼
5d:
-4.47%
30d:
-2.38%
90d:
+2.89%
HOLD
MODERATE Confidence
Analysis Updated: Feb 6, 2026 12:00 AM ET
Earnings: Mar 12, 2026
0d
Get Alerted When GBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GBIO is currently trading at $5.34, which is considered fair based on recent price action.
Technical Outlook: Technically, GBIO is in a downtrend. The price is currently testing key support at $5.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GBIO is in a downtrend. The price is currently testing key support at $5.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
58/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
58.9%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-7.0%)
- NEUTRAL: Near Wall St target ($5.25)
Support & Resistance Levels
Support Level
$5.44
Resistance Level
$5.77
Current Trend
Downtrend
Technical data as of
Feb 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.69
Wall Street Target
$5.25
(-1.7%)
Revenue Growth (YoY)
-78.9%
Share & Embed Analysis
Last updated: June 05, 2026 9:31 AM ET
Data refreshes hourly during market hours. Next update: 10:31 AM
Data refreshes hourly during market hours. Next update: 10:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1023 | 60 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$82 | 61 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 54 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 61 BUY |
